# @newsnation on YouTube

- **Type:** Video
- **Original URL:** https://youtube.com/watch?v=dshawEw3mkU
- **Gondola URL:** https://gondola.cc/posts/8004493-newsnation-youtube
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/thumbnails/5b128e9446.jpg
- **Posted:** 2023-07-18T12:24:59.000+00:00
- **Account Owner:** NewsNation (@newsnation) — https://gondola.cc/newsnation

## Caption

Eli Lilly and Co. is seeking FDA approval for Donanemab. If cleared, it would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease. Dr. Ian Smith weighs out the pros and cons of this drug's ability to slow Alzheimer's.

Watch #MorningInAmerica: https://www.newsnationnow.com/joinus

#Alzheimers #FDA #Donanemab

Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Adrienne Bankert. Weekdays starting at 7a/6C. #MorningInAmerica

NewsNation is your source for fact-based, unbiased news for all America. 

More from NewsNation: https://www.newsnationnow.com/
Get our app: https://trib.al/TBXgYpp
Find us on cable: https://trib.al/YDOpGyG
How to watch on TV or streaming: https://trib.al/Vu0Ikij

## Stats

- **Views:** 424
- **Likes:** 12
- **Shares:** 0
- **Comments:** 5

## Tags

donanemab, alzheimers, morninginamerica, fda

---
Copyright (c) Gondola